136 related articles for article (PubMed ID: 25355039)
1. Prognostic value of COX-2, P53, and EZH-2 evaluated by quantitative image analysis in premalignant and malignant breast lesions.
Nicolopoulou-Stamati P; Tsipis A; Chelidonis G; Patsouris E; Athanassiadou P; Gonidi M; Athanassiadou AM
Diagn Cytopathol; 2015 Apr; 43(4):294-300. PubMed ID: 25355039
[TBL] [Abstract][Full Text] [Related]
2. Significance of cyclooxygenase 2, EZH-2 polycomb group and p53 expression in actinic keratosis and squamous cell carcinomas of the skin.
Athanassiadou AM; Lazaris AC; Patsouris E; Tsipis A; Chelidonis G; Aroni K
Am J Dermatopathol; 2013 Jun; 35(4):425-31. PubMed ID: 23095338
[TBL] [Abstract][Full Text] [Related]
3. Enhancer of zeste homologue 2 expression in breast carcinoma smears in relationship with p53, Ki-67 and other prognostic parameters.
Athanassiadou AM; Tsipis A; Patsouris E; Gonidi M; Nicolopoulou-Stamati P; Chelidonis G; Athanassiadou P
Acta Cytol; 2011; 55(2):180-6. PubMed ID: 21325804
[TBL] [Abstract][Full Text] [Related]
4. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions.
Hermanova M; Trna J; Nenutil R; Dite P; Kala Z
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):732-9. PubMed ID: 18617777
[TBL] [Abstract][Full Text] [Related]
5. Single cell multiple biomarker analysis in archival breast fine-needle aspiration specimens: quantitative fluorescence image analysis of DNA content, p53, and G-actin as breast cancer biomarkers.
Rao JY; Apple SK; Hemstreet GP; Jin Y; Nieberg RK
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1027-33. PubMed ID: 9829712
[TBL] [Abstract][Full Text] [Related]
6. Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology.
Apostolou G; Apostolou N; Biteli M; Kavantzas N; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2014 Feb; 42(2):134-42. PubMed ID: 23729350
[TBL] [Abstract][Full Text] [Related]
7. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
[TBL] [Abstract][Full Text] [Related]
8. Different proliferative patterns characterize different preinvasive breast lesions.
Viacava P; Naccarato AG; Bevilacqua G
J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590
[TBL] [Abstract][Full Text] [Related]
9. [Fine needle aspiration cytology diagnosis of ductal lesions of breast].
Di F; Wong NL
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):467-72. PubMed ID: 21055176
[TBL] [Abstract][Full Text] [Related]
10. p16(INK4a) expression and breast cancer risk in women with atypical hyperplasia.
Radisky DC; Santisteban M; Berman HK; Gauthier ML; Frost MH; Reynolds CA; Vierkant RA; Pankratz VS; Visscher DW; Tlsty TD; Hartmann LC
Cancer Prev Res (Phila); 2011 Dec; 4(12):1953-60. PubMed ID: 21920875
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclooxygenase-2 (COX-2) and p53 in neighboring invasive and in situ components of breast tumors.
Serra KP; Sarian LO; Rodrigues-Peres RM; Vassallo J; Soares FA; Pinto GA; da Cunha IW; Shinzato JY; Derchain SF
Acta Histochem; 2012 May; 114(3):226-31. PubMed ID: 21683430
[TBL] [Abstract][Full Text] [Related]
12. Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues.
Ding L; Erdmann C; Chinnaiyan AM; Merajver SD; Kleer CG
Cancer Res; 2006 Apr; 66(8):4095-9. PubMed ID: 16618729
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
14. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.
Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ
Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1, retinoblastoma, p53, and Her2/neu protein expression in preinvasive breast pathologies: correlation with vascularity.
Heffelfinger SC; Yassin R; Miller MA; Lower EE
Pathobiology; 2000; 68(3):129-36. PubMed ID: 11174070
[TBL] [Abstract][Full Text] [Related]
17. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
[TBL] [Abstract][Full Text] [Related]
19. Molecular and biologic markers of premalignant lesions of human breast.
Krishnamurthy S; Sneige N
Adv Anat Pathol; 2002 May; 9(3):185-97. PubMed ID: 11981114
[TBL] [Abstract][Full Text] [Related]
20. bcl-2 expression in the spectrum of preinvasive breast lesions.
Siziopikou KP; Prioleau JE; Harris JR; Schnitt SJ
Cancer; 1996 Feb; 77(3):499-506. PubMed ID: 8630957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
